公司资料
Decipher Biosciences 股价、新闻与催化剂
- 股票代码:
- DECI
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
目前无法获取 DECI 的收盘价变动背景。
公司概览
业务概览
Decipher Biosciences was a precision oncology diagnostics company focused on genomic tools for cancer risk and treatment selection before being acquired. Its story was rooted in molecular diagnostics and data-driven oncology decisions.
所在地与行业分类
Decipher was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in oncology diagnostics rather than therapeutics.
商业模式特征
The company depended on diagnostic adoption, reimbursement, and the ability to make genomic testing clinically indispensable. Investors historically watched test utilization and strategic interest.
生物医药行业定位
Decipher belongs to the historical precision-oncology diagnostics category. It is best thought of as a molecular-testing business that became valuable through strategic fit.
未来催化剂
- Decipher Biosciences is now a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. There is no active standalone growth story left.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。